期刊名称：JOURNAL OF FORENSIC SCIENCES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The official publication of the American Academy of Forensic Sciences, edited and produced by ASTM. Includes papers on original investigations, observations, scholarly inquiries, and reviews. Its scope encompasses forensic toxicology, pathology, psychiatry, immunology, jurisprudence, criminalistics, odontology, physical anthropology, and questioned documents and engineering. Also contains papers dealing with forensic-oriented aspects of the social sciences. All papers peer-reviewed.
Instructions to Authors
The Journal of Forensic Sciences publishes original material in the following categories:
Paper --- full-length research report
Technical Note --- description of a technical aspect of a field or issue, report on a procedure or method, or work on validation of techniques or methodologies. Usually shorter than papers.
Brief Communication --- very brief technical communication, shorter than a typical Technical Note. Brief Communications should generally be no more than 4-5 manuscript pages, including references, figures and tables.
Case Report --- usually brief description or analysis of an unusual case or a small series or cases
Review --- full-length paper reviewing the state of the art or the published literature in a particular area of sufficiently broad interest to the readership
Letter --- usually a discussion of a previously published item, or commentary on the Journal or an issue of interest to the Academy. Publication of letters is at the sole discretion of the Editor. Letters commenting on previously published items are ordinarily shared with the original authors to afford them an opportunity to respond to the commentary.
Response to Letter --- usually author(s) response to a Letter commenting on their published work
Editorial or Invited Commentary --- commentary, invited by the Editor
electronic media. This policy does not preclude consideration of a paper that has been rejected by another journal or of a complete report that follows publication of a preliminary report, usually in the form of an abstract. Nor does it prevent consideration of a paper that has been presented at a scientific meeting if not published in full in a proceedings or similar publication.
Press reports of the meeting will not usually be considered as breaches of this rule, but such reports should not be amplified by additional data or copies of tables and illustrations.
When submitting a paper, an author should always make a full statement to the editor about all submissions and previous reports might be regarded as prior or duplicate publication of the same or very similar work. Copies of such material should be included with the submitted paper to help the editor decide how to deal with the matter.
Multiple publication-that is, the publication more than once of the same study, irrespective of whether the wording is the same-is rarely justified. Secondary publication in another language is one possible justification, providing the following conditions are met: (1) the editors of both journals concerned are fully informed; the editor concerned with secondary publication should have a photocopy, reprint, or manuscript of the primary version; (2) The priority of the primary publication is by a publication interval of at least 2 weeks; (3) The paper for secondary publication is written for a different group of readers and is not simply a translated version of the primary paper; an abbreviated version will often be sufficient; (4) The secondary version reflects faithfully the data and interpretations of the primary version; (5) A footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper was edited, and is being published, for a national audience in parallel with a primary version based on the same data and interpretations. A suitable footnote might read as follows: "This article is based on a study first reported in the [title of journal, with full reference]."
Multiple publication other than as defined above is unacceptable. If authors violate this rule, they may expect appropriate editorial action to be taken.
PREPARATION OF MANUSCRIPT
Type or print out the manuscript on white bond paper, 216 x 279 mm (8 1/2 X 11 in.), or ISO A4 (212 X 297 mm), with margins of at least 25 mm (1 in.). Type or print on only one side of the paper. Use double-spacing throughout, including title page, abstract, text, acknowledgments, references, individual tables, and legends. Number pages consecutively, beginning with the title page. Put the page number in the upper right-hand corner of each page.
Title Page
The title page should carry: (a) the title of the article, which should be concise but informative; (b) first name, middle initial, and last name of each author, with highest academic degree(s); (c) institutional affiliation, name of department(s) and/or institution(s) to which the work should be attributed; (d) official disclaimers, if any; (e) name and address of author responsible for correspondence about the manuscript; (f) source(s) of support in the form of grants, equipment, drugs, or all of these; (g) a statement of where the work has been presented orally or in poster form at professional meetings; and (h) a short running header of no more than 40 characters (count letters and spaces) placed near the bottom of the title page and identified.
Institutional affiliations of authors should be numbered footnotes to the individual’s name and highest academic degree.
If an author’s present address differs from the institution in which the work was done, and is attributed, indicate a “Present address” for that author.
A footnote to the title of the manuscript (generally designated by a superscript *) should give statements about where the work has been presented at professional meetings, and should identify any sources of support.
Authorship
All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the coauthors. Each author should have participated sufficiently in the work to take public responsibility for the content.
Authorship credit should be based only on substantial contributions to a) conception and design, or analysis interpretation of data; and to b) drafting the article or revising it critically for important intellectual content; and on c) final approval of the version to be published. Conditions a), b), and c) must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.
Editors may require authors to justify the assignment of authorship. Increasingly, multi-center trials or work are attributed to a corporate author. All members of the group who are named as authors, either in the authorship position below the title or in a footnote, should fully meet the criteria for authorship as defined in the Uniform Requirements. Group members who do not meet these criteria should be listed, with their permission, under Acknowledgments or in an appendix (see Acknowledgments).
Abstract and Key Words
Book Review --- review of a book or other publication of interest to the forensic sciences or closely related fields.
Special Communication --- occasional communication of an editorial or newsworthy nature
For the Record --- a summary of population genetic data published under the condition that the complete data set be available at a readily accessible world wide web site.
Papers, technical notes, brief communications, case reports and reviews are subjected to full peer review.
Previously published material is not acceptable. Material from previously published work must be quoted exactly and adequately referenced. Use of previously published figures, tables, etc., require the written permission of the copyright owner of the prior work. Manuscripts submitted as papers, technical notes, brief communications, case reports, or reviews, are accepted for consideration with the understanding that their essential contents, including text, tables and figures, have neither been previously published nor concurrently submitted to another journal. Work must not be submitted to another journal unless and until the Journal of Forensic Sciences formally declines to publish it. The above-discussed prohibitions do not apply to abstracts or summaries published in connection with professional meetings, or press reports resulting from formal or oral presentation.
The Journal of Forensic Sciences reserves the right of first consideration for publication of any work accepted for presentation at an annual meeting of the American Academy of Forensic Sciences (AAFS), and authors must not submit their work elsewhere for a period of six months following the annual meeting at which the work was presented. If a manuscript has not been accepted for publication, or is not under active consideration by the Journal, at the end of the six-month period, the interest of the Journal in the manuscript automatically terminates.
Upon acceptance for publication, manuscripts become the copyright property of the American Society for Testing and Materials (ASTM). Author(s) of manuscripts accepted for publication must complete a Paper Submittal Form that will be furnished by the Editor along with notification of full acceptance. This form must be signed by all authors, indicating complete understanding of the work and concurrence in it. Signature(s) of authors also serve to transfer copyright in the work to ASTM. It is understood that for certain work by employees of U.S. or foreign governments, whose manuscripts have been prepared as part of their official duties, copyright is not available in the United States.
Acceptance of manuscripts submitted for publication is the responsibility of the Publications Committee of the AAFS, Editorial Board of the Journal of Forensic Sciences, and the editor, and occurs only after review of the manuscript in accordance with current operating rules. Review of submitted manuscripts may ordinarily be expected to be completed within 90 days.
Authors, members of the Editorial Board, invited guest reviewers, the editor, and others involved in the publication process are expected to conform to established policies concerning confidentiality, conflicts of interest, release of accepted manuscripts prior to actual publication, and the protection of anonymity of patients and victims [J Forensic Sci 1995; 40 (3-6), 1996; 41(1-6), 1997; 42(1-6), 1998;43(1-6), and in selected issues thereafter; and see below].
The Journal requires that authors submitting manuscripts for peer review (papers, technical notes, case reports, brief communications) have obtained required approval(s) for submission from authorized principals and/or internal reviews in their laboratories and/or organizations.
Submission of Manuscripts
The Journal of Forensic Sciences requirements for manuscripts are generally in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. These requirements may be found published in one of the following: (1) J Forensic Sci 1995 Mar-Nov;40(2-6), 1996 41, 1997; 42, 1998;43 and selected issues thereafter; (2) JAMA 1993 May 5;269:2282-6; (3) N Engl J Med 1991 Feb 7;324(6):424-8; (4) Can Med Assoc J 1991;144(6):673-80; (5) BMJ 1991 Feb 9;302(6772):338-41; or (6) Med J Aust 1991;155(3):197-200.
The following integrates the Uniform Requirements for Manuscripts Submitted to Biomedical Journals as they apply to the Journal of Forensic Sciences with the specific requirements of this journal.
Manuscripts must be written in English. An original and three complete copies should be sent to: Dr. Michael A. Peat, Editor, Journal of Forensic Sciences, 6700 Woodlands Parkway, Suite 230-308, The Woodlands, TX 77381,USA. An original and three complete copies of all tables and figures (including photographs and line drawings) must be included.
Type the manuscript double-spaced, including title page, abstract, text, acknowledgments, references, tables, and legends.
Each manuscript component should begin on a new page, in the following sequence: title page, abstract and key words, text, acknowledgments, references, tables (each table complete with title and footnotes on a separate page), and legends for illustrations.
Illustrations must be good-quality, unmounted glossy prints, usually 127 x 173 mm (5 x 7 in.), but no larger than 203 x 254 mm (8 x 10 in.). Submit an original and three complete copies of manuscripts and illustrations in a heavy-paper envelope. The submitted manuscript should be accompanied by a cover letter, as described below, and permissions to reproduce previously published material or to use illustrations that may identify human subjects. Authors should keep copies of everything submitted.
Manuscript submissions should be accompanied by a cover letter specifying the name, full mailing address and telephone/fax numbers and e-mail of the person who will act as corresponding author, and the category (paper, technical note, etc.) under which the item is submitted. The editor reserves the right to publish the manuscript in a category different from the one specified by the author(s) at submission.
The cover letter should also specify, if applicable, information about possible duplicate publication problems, financial or other relationships that could give rise to conflicts of interest, and any other information the editor may need to make an informed decision in accordance with established policies and practices. The manuscript must be accompanied by copies of any permissions to reproduce published material, to reproduce illustrations or report sensitive personal information about identifiable persons, or to name persons for their contributions.
If color artwork is submitted, and if the authors believe color art is necessary to the presentation of their work, the cover letter should indicate that one or more authors or their institutions are prepared to pay the substantial costs associated with color art reproduction.
Only the corresponding author need sign the cover letter. The corresponding author's
signature on the submission cover letter signifies: a) that all required approvals and/or reviews have been obtained from authorized principals in the laboratory and/or organization in which the work was performed The cover letter can also explicitly state that such approvals have been obtained. The editor reserves the right to request explicit, written approval of authorized laboratory and/or organization principals before the work is accepted by the journal for peer review. and b) that all authors have read the manuscript, concur in its contents, are qualified for authorship by the criteria stated in these requirements, and believe the submission to represent honest work.
The editor reserves the right to request explicit, written clarification of individual author’s roles, their concurrence in the manuscript content, or any other issue that must be resolved prior to accepting the manuscript for peer review.
The Journal does not accept submissions of manuscripts from third parties without the explicit, written permission of the author(s).
PRIOR AND DUPLICATE PUBLICATION
As noted, this journal does not consider for publication a paper on work that has already been reported in a published paper or that is described in a paper submitted or accepted for publication elsewhere in print or in
electronic media. This policy does not preclude consideration of a paper that has been rejected by another journal or of a complete report that follows publication of a preliminary report, usually in the form of an abstract. Nor does it prevent consideration of a paper that has been presented at a scientific meeting if not published in full in a proceedings or similar publication.
Press reports of the meeting will not usually be considered as breaches of this rule, but such reports should not be amplified by additional data or copies of tables and illustrations.
When submitting a paper, an author should always make a full statement to the editor about all submissions and previous reports might be regarded as prior or duplicate publication of the same or very similar work. Copies of such material should be included with the submitted paper to help the editor decide how to deal with the matter.
Multiple publication-that is, the publication more than once of the same study, irrespective of whether the wording is the same-is rarely justified. Secondary publication in another language is one possible justification, providing the following conditions are met: (1) the editors of both journals concerned are fully informed; the editor concerned with secondary publication should have a photocopy, reprint, or manuscript of the primary version; (2) The priority of the primary publication is by a publication interval of at least 2 weeks; (3) The paper for secondary publication is written for a different group of readers and is not simply a translated version of the primary paper; an abbreviated version will often be sufficient; (4) The secondary version reflects faithfully the data and interpretations of the primary version; (5) A footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper was edited, and is being published, for a national audience in parallel with a primary version based on the same data and interpretations. A suitable footnote might read as follows: "This article is based on a study first reported in the [title of journal, with full reference]."
Multiple publication other than as defined above is unacceptable. If authors violate this rule, they may expect appropriate editorial action to be taken.
PREPARATION OF MANUSCRIPT
Type or print out the manuscript on white bond paper, 216 x 279 mm (8 1/2 X 11 in.), or ISO A4 (212 X 297 mm), with margins of at least 25 mm (1 in.). Type or print on only one side of the paper. Use double-spacing throughout, including title page, abstract, text, acknowledgments, references, individual tables, and legends. Number pages consecutively, beginning with the title page. Put the page number in the upper right-hand corner of each page.
Title Page
The title page should carry: (a) the title of the article, which should be concise but informative; (b) first name, middle initial, and last name of each author, with highest academic degree(s); (c) institutional affiliation, name of department(s) and/or institution(s) to which the work should be attributed; (d) official disclaimers, if any; (e) name and address of author responsible for correspondence about the manuscript; (f) source(s) of support in the form of grants, equipment, drugs, or all of these; (g) a statement of where the work has been presented orally or in poster form at professional meetings; and (h) a short running header of no more than 40 characters (count letters and spaces) placed near the bottom of the title page and identified.
Institutional affiliations of authors should be numbered footnotes to the individual’s name and highest academic degree.
If an author’s present address differs from the institution in which the work was done, and is attributed, indicate a “Present address” for that author.
A footnote to the title of the manuscript (generally designated by a superscript *) should give statements about where the work has been presented at professional meetings, and should identify any sources of support.
Authorship
All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the coauthors. Each author should have participated sufficiently in the work to take public responsibility for the content.
Authorship credit should be based only on substantial contributions to a) conception and design, or analysis interpretation of data; and to b) drafting the article or revising it critically for important intellectual content; and on c) final approval of the version to be published. Conditions a), b), and c) must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.
Editors may require authors to justify the assignment of authorship. Increasingly, multi-center trials or work are attributed to a corporate author. All members of the group who are named as authors, either in the authorship position below the title or in a footnote, should fully meet the criteria for authorship as defined in the Uniform Requirements. Group members who do not meet these criteria should be listed, with their permission, under Acknowledgments or in an appendix (see Acknowledgments).
Abstract and Key Words
The second page should carry an abstract of no more than 150 words. This journal uses unstructured abstracts. The abstract should briefly state the purposes of the study or investigation, basic procedures (selection of study subjects or laboratory animals; observational and analytical methods), main findings (give specific data and their statistical significance, if possible), and the principal conclusions. Emphasize new and important aspects of the study or observations.
Below the abstract provide, and identify as such, 3 to 10 key words or short phrases that will assist indexers in cross-indexing the article and may be published with the abstract. Use terms from the medical subject headings (MeSH) list of Index Medicus; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used. The first key word is forensic science; the second and subsequent words should assist abstracters in properly categorizing the work so that it will be found in journal article data bases by interested researchers. Frequently, the second key word represents a subfield of forensic science, e.g. forensic anthropology, forensic pathology, or DNA typing. In manuscripts on DNA typing, every locus involved in the study should be listed as a separate key word. Do not use abbreviations for key words, e.g., polymerase chain reaction, not PCR; gas chromatography-mass spectrometry, not GC-MS.
Text
The text of observational and experimental articles is usually-but not necessarily-divided into sections with headings. This journal does not use an “Introduction” heading. The introductory text begins on the first text page. Other typical headings include Methods (or Materials and Methods), Results, and Discussion. Long articles may need subheadings within the sections to clarify their content, especially the Results and Discussion sections. Other types of articles such as case reports or reviews are likely to need different headings and subheadings. Generally, avoid overuse of subheadings, especially in the Methods section.
Introduction
In this journal, the text component of the manuscript begins with an introduction, but we do not use the “Introduction” heading. State the purpose of the article. Summarize the rationale for the study or observation. Give only strictly pertinent references, and do not review referenced articles extensively. Do not include data or conclusions from the work being reported.
Methods
Describe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the methods, apparatus (manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods, that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. Generally avoid the overuse of subheadings in the Methods section. Describe the methods and materials in narrative style, not in the style of a laboratory procedure handout.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration of 1975, as revised in 1983. Do not use patient's names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or the National Research Council's guide for, or any national law on, the care and use of laboratory animals was followed.
Statistics
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals).
Avoid sole reliance on statistical hypothesis testing, such as the use of P values, which fails to convey important quantitative information. Discuss eligibility of experimental subjects. Give details about randomization. Describe the methods for and success of any blinding of observations. Report treatment
complications. Give numbers of observations. Report losses to observation (such as dropouts from a clinical trial). References for study design and statistical methods should be to standard works (with pages stated) when possible rather than to papers in which the designs or methods were originally reported. Specify any general-use computer programs used.
Put a general description of methods in the Methods section. When data are summarized in the Results section, specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables.
Avoid non-technical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define statistical terms, abbreviations, and most symbols.
Results
Present your results in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations.
Discussion
Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. Include in the Discussion section the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by your data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.
In shorter manuscripts, such as those intended to be Technical Notes or Brief Communications, the Results and Discussion sections should be combined.
Acknowledgments
The Acknowledgements section immediately precedes the Reference list. Here, specify contributions that need acknowledging but do not justify authorship, such as general support by a department chair or acknowledgments of technical help. Persons who have contributed intellectually to the paper but whose contributions do not justify authorship may be named and their function or contribution described---for example, "scientific adviser," "critical review of study proposal," "data collection," or "participation in clinical trial." Such persons must have given their permission to be named.
Authors are responsible for obtaining written permission from persons acknowledged by name, because readers may infer their endorsement of the data and conclusions. Technical help should be acknowledged in a paragraph separate from those acknowledging other contributions.
Acknowledgements of financial support should appear as footnotes to the title of the paper on the Title Page.
References
The heading of the reference list should be "References," and it should contain only published or in-press references cited by number in the test. Published abstracts (duly noted as being abstracts), printed manufacturers' protocols or instructions, and world wide web site URLs may be validly cited as references. Personal communications and submitted manuscripts are not valid references. Personal communications should be cited in the text, in parentheses, at the appropriate location.
Number references consecutively in the order in which they are first mentioned in the text. Identify references in tables, and legends by Arabic numerals. References cited only in tables or legends should be numbered in accordance with a sequence established by the first identification in the text of the particular table or figure. Within the text, tables, or figures, cite references by Arabic numeral in parentheses. Within the reference list, number the references 1., 2., 3., etc.
References in the reference list should be in accord with Uniform Requirements … style of the examples given below. This style is based with slight modifications on the formats used by the U.S. National Library of Medicine in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Consult List of Journals Indexed in Index Medicus, published annually as a separate publication by the library and as a list in the January issue of Index Medicus.
The references must be verified by the author(s) against the original documents. Examples of correct forms of references are given below.
Articles in Journals
1) Standard journal article (List all authors, but if the number exceeds six, give six followed by et al.)
You CH, Lee KY, Chey RY, Menguy R. Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology 1980 Aug;79(2):311-4.
As an option, if a journal carries continuous pagination throughout a volume, the month and issue number may be omitted.
You CH, Lee KY, Chey RY, Menguy R. Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology 1980;79:311-4.
Goate AM, Haynes AR, Owen MJ, Farrall M, James LA, Lai LY et al. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet 1989;1:352-5.
2) Organization as author
The Royal Marsden Hospital Bone-Marrow Transplantation Team. Failure of syngeneic bone-marrow graft without preconditioning in post-hepatitis marrow aplasia. Lancet 1977;2:742-4.
3) No author given
Coffee drinking and cancer of the pancreas [editorial]. BMJ 1981;283:628.
4) Article not in English
Massone L, Borghi S, Pestarino A, Piccini R, Gambini G. Localisations palmaires purpuriques de la dermatite herpetiforme. Ann Dermatol Venereol 1987;114:1545-7.
5) Volume with supplement
Magni F, Rossoni G, Berti F. BN-52021 protects guinea-pig from heart anaphylaxis. Pharmacol Res Commun 1988;20 Suppl 5:75-8.
6) Issue with supplement
Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore R. The natural history of tardive dyskinesia. J Clin Psychopharmacol 1988;8(4 Suppl):31S-37S.
7) Volume with part
Hanly C. Metaphysics and innateness: a psychoanalytic perspective. Int J Psychoanal 1988;69(Pt 3):389-99.
8) Issue with part
Edwards L, Meyskens F, Levine N. Effect of oral isotretinoin on dysplastic nevi. J Am Acad Dermatol 1989;20(2 Pt 1):257-60.
9) Issue with no volume
Baumeister AA. Origins and control of stereotyped movements. Monogr Am Assoc Ment Defic 1978;(3):353-84
10) No issue or volume
Danoek K. Skiing in and through the history of medicine. Nord Medicinhist Arsb 1982;86-100.
11) Pagination in roman numerals
Ronne Y. Ansvarsfallen Blodtransfusion till fel patient. Vardfacket 1989;13:XXXVI-XXVII.
12) Type of article indicated as needed
Spargo PM, Manners JM. DDAVP and open heart surgery [letter]. Anaesthesia 1989;44:363-4.
13) Article containing retraction
Shishido A. Retraction notice. Effect of platinum compounds on murine lymphocyte mitogenesis [Retraction of Alsabti EA, Ghalib ON, Salem MN. In: Jpn J Med Sci Biol 1979;32:53-65]. Jpn J Med Sci Biol 1980;33:235-7.
14) Article retracted
Alsabti EA, Ghalib ON, Sale MN. Effect of platinum compounds on murine lymphocyte mitogenesis [Retracted by Shishido A. In: Jpn J Med Sci Biol 1980;33:235-7]. Jpn J Med Sci Biol 1979;32:53-65.
15) Article containing comment
Piccoli A, Bossatti A. Early steroid therapy in IgA neuropathy: still an open question [comment] Nephron 1989;51:289-91. Comment on: Nephron 1988;48:12-7.
16) Article commented on
Kobayashi Y, Fujii K, Hiki Y, Tateno S, Kurokawa A, Kamiyama M. Steroid therapy in IgA neuropathy: a retrospective study in heavy proteinuric cases [see comments]. Nephron 1988;48:12-7. Comment in: Nephron 1989;51:289-91.
17) Article with published erratum
Schofield A. The CAGE questionnaire and psychological health [published erratum appears in Br J Addict 1989;84:701]. Br J Addict 1988;83;761-4.
Books and Other Monographs
18) Personal author(s)
Colson JH, Armour WJ. Sports injuries and their treatment. 2nd rev. ed. London: S. Paul, 1986
19) Editor(s), compiler as author
Diener HC, Wilkinson M, editors. Drug-induced headache. New York: Springer-Verlag, 1988
20) Organization as author and publisher
Virginia Law Foundation. The medical and legal implications of AIDS. Charlottesville: The Foundation, 1987.
21) Chapters in a book
Weinstein L, Swartz MN. Pathologic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, editors. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders, 1974;457-72.
22) Conference proceedings
Vivian VL, editor. Child abuse and neglect: a medical community response. Proceedings of the First AMA National Conference on Child Abuse and Neglect; 1984 Mar 30-31; Chicago. Chicago: American Medical Association, 1985.
23) Conference paper
Harley NH. Comparing radon daughter dosimetric and risk models. In: Gammage RB, Kaye SV, editors. Indoor air and human health. Proceedings of the Seventh Life Sciences Symposium; 1984 Oct 29-31; Knoxville (TN). Chelsea (Ml): Lewis, 1985;69-78.
24) Scientific or technical report
Akutsu T. Total heart replacement device. Bethesda (MD): National Institutes of Health, National Heart and Lung Institute; 1974 Apr. Report No.: NIH-NHLI-691 218514.
25) Dissertation
Youssef NM. School adjustment of children with congenital heart disease [dissertation]. Pittsburgh (PA): Univ. of Pittsburgh, 1988.
26) Patent
Harred JF, Knight AR, McIntyre JS, inventors. Dow Chemical Company, assignee. Epoxidation process. US patent 3,654,317. 972 Apr 4.
Other Published Material
27) Newspaper article
Rensberger B, Specter B. CFCs may be destroyed by natural process. The Washington Post 1989 Aug 7; Sect. A:2 (col. 5).
Editorial Board
ASTM Staff Contact:
Qiu Ping Gong (610)832-9648, qgong@astm.org
|
刊名字顺( Alphabetical List of Journals):
返回页首 